[1] KUNNUMAKKARA A B,BORDOLOI D,PADMAVATHI G,et al.Curcumin,the golden nutraceutical:multitargeting for multiple chronic diseases[J].Br J Pharmacol,2017,174(11):1325-1348.
[2] SAHEBKAR A.Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?[J] Biofactors,2013,39(2):197-208.
[3] AMIN F,ISLAM N,ANILA N,et al.Clinical efficacy of the co-administration of turmeric and black seeds (kalongi) in metabolic syndrome-a double blind randomized controlled trial-tak-mets trial[J].Complement Ther Med,2015,23(2):165-174.
[4] CHUENGSAMARN S,RATTANAMONGKOLGUL S,LUECHAPUDIPORN R,et al.Curcumin extract for prevention of type 2 diabetes[J].Diabetes Care,2012,35(11):2121-2127.
[5] CHUENGSAMARN S,RATTANAMONGKOLGUL S,PHONRAT B,et al.Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract:a randomized controlled trial[J].J Nutr Biochem,2014,25(2):144-150.
[6] KHAJEHDEHI P,PAKFETRAT M,JAVIDNIA K,et al.Oral supplementation of turmeric attenuates proteinuria,transforming growth factor-beta and interleukin-8 levels in patients with overt type 2 diabetic nephropathy:a randomized,double-blind and placebo-controlled study[J].Scand J Urol Nephrol,2011,45(5):365-370.
[7] MAITHILI K S N,SRIDHAR M G,SWAMINATHAN R P,et al.Efficacy of turmeric as adjuvant therapy in type 2 diabetic patients[J].Indian J Clin Biochem,2015,30(2):180-186.
[8] MOHAMMADI A,SAHEBKAR A,IRANSHAHI M,et al.Effects of supplementation with curcuminoids on dyslipidemia in obese patients:a randomized crossover trial[J].Phytother Res,2013,27(3):374-379.
[9] PANAHI Y,HOSSEINI M S,KHALILI N,et al.Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome:a randomized controlled trial and an updated meta-analysis[J].Clin Nutr,2015,34(6):1101-1108.
[10] PANAHI Y,HOSSEINI M S,KHALILI N,et al.Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome:a post-hoc analysis of a randomized controlled trial[J].Biomed Pharmacother,2016,82:578-582.
[11] PANAHI Y,KHALILI N,HOSSEINI M S,et al.Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome:results of a randomized controlled trial[J].Complement Ther Med,2014,22(5):851-857.
[12] PANAHI Y,KIANPOUR P,MOHTASHAMI R,et al.Curcumin lowers serum lipids and uric acid in subjects with nonalcoholic fatty liver disease:a randomized controlled trial[J].J Cardiovasc Pharmacol,2016,68(3):223-229.
[13] RAHIMI H R,MOHAMMADPOUR A H,DASTANI M,et al. The effect of nano-curcumin on HbA1c,fasting blood glucose,and lipid profile in diabetic subjects:a randomized clinical trial[J].Avicenna J Phytomed,2016,6(5):567-577.
[14] RAHMANI S,ASGARY S,ASKARI G,et al.Treatment of non-alcoholic fatty liver disease with curcumin:a randomized placebo-controlled trial[J].Phytother Res,2016,30(9):1540-1548.
[15] YANG Y S,SU Y F,YANG H W,et al.Lipid-lowering effects of curcumin in patients with metabolic syndrome:a randomized,double-blind,placebo-controlled trial[J].Phytother Res,2014,28(12):1770-1777.
[16] SAHEBKAR A.Curcuminoids for the management of hypertriglyceridaemia[J].Nat Rev Cardiol,2014,11(2):123.
[17] SAHEBKAR A.A systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels[J].Clin Nutr,2014,33(3):406-414.
[18] ESMAILY H,SAHEBKAR A,IRANSHAHI M,et al.An investigation of the effects of curcumin on anxiety and depression in obese individuals:a randomized controlled trial[J].Chin J Integr Med,2015,21(5):332-338.
[19] LASTRA G,MANRIQUE C.Perivascular adipose tissue,inflammation and insulin resistance:link to vascular dysfunction and cardiovascular disease[J].Horm Mol Biol Clin Investig,2015,22(1):19-26.
[20] 许崇德,成之福.姜黄素改善2型糖尿病的机制研究进[J].医药导报,2016,35(11):1234-1237.
[21] SUN Y,PENG M L.Recent advances in curcumin and its derivatives for treatment of liver diseases[J].Yao Xue Xue Bao,2014,49(11):1483-1490.
[22] GULSEREN I,GURI A,CORREDIG M.Effect of interfacial composition on uptake of curcumin-piperine mixtures in oil in water emulsions by caco-2 cells[J].Food Funct,2014,5(6):1218-1223.
[23] HU L,SHI Y,LI J H,et al.Enhancement of oral bioavailability of curcumin by a novel solid dispersion system[J].AAPS PharmSciTech,2015,16(6):1327-1334.
[24] ADITYA N P,YANG H,KIM S,et al.Fabrication of amorphous curcumin nanosuspensions using beta-lactoglobulin to enhance solubility,stability,and bioavailability[J].Colloids Surf B Biointerfaces,2015,127:114-121. |